{"id":"W2945349403","doi":"10.1177/1758835919850367","title":"Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine <i>versus</i> FOLFIRINOX in advanced pancreatic cancer: a systematic review","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Health Services","funders":"Celgene","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Irinotecan; Internal medicine; Oxaliplatin; Neutropenia; Oncology; Pancreatic cancer; Gastroenterology; Cancer; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006233881,0.001015711,0.02258932,0.0009368233,0.00004922141,0.000005620006,0.0009905145,0.001004184,0.0005371016],"category_scores_gemma":[0.001905364,0.0007104807,0.0007490254,0.002316033,0.001114172,0.0001775085,0.0002637916,0.002440526,0.0001017895],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.00439572,"about_ca_system_score_gemma":0.008114756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003012265,"about_ca_topic_score_gemma":0.001455067,"domain_scores_codex":[0.9858143,0.006559344,0.003801572,0.001154771,0.001496647,0.001173385],"domain_scores_gemma":[0.9744994,0.0218392,0.001723178,0.001201457,0.0002873911,0.0004493847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002151945,0.0006866721,0.000459267,0.8441633,0.001086124,0.0003811388,0.0001539869,0.000004855321,9.868287e-7,0.0008601652,0.00001695755,0.1500346],"study_design_scores_gemma":[0.01109516,0.002716854,0.000161041,0.8574945,0.009420834,0.0001419312,0.0001551242,0.0001563058,0.000001139176,0.0002166948,0.1178688,0.0005716743],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002272313,0.9747282,0.00007845595,0.0001986218,0.0007178463,0.01397448,0.00004002471,0.00004786048,0.009987243],"genre_scores_gemma":[0.0005258025,0.9913079,0.0003634924,0.0003959638,0.0001137265,0.006521532,0.0001246567,0.0000959329,0.0005509585],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1494629,"threshold_uncertainty_score":0.9998609,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1137865024179143,"score_gpt":0.5148520294269145,"score_spread":0.4010655270090003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}